Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes

The purpose of this study is to evaluate the efficacy and safety of 2 doses of dulaglutide in Japanese participants with type 2 diabetes. The study duration is approximately 58 weeks.

sulfonylurea
alpha-glucosidase inhibitor
body mass index
hemoglobin a1c
  • 0 views
  • 13 Jun, 2021
  • 40 locations
Oral Anti Diabetic Agents in the Hospital

The randomized controlled clinical trial will assess whether continuation of home oral antidiabetic agents during hospitalization can be used as a safe and effective alternative to insulin

flash
hypoglycemia
diabetic ketoacidosis
continuous glucose monitoring
insulin
  • 10 views
  • 04 Apr, 2021
  • 3 locations
Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients

GLP-1 receptor agonists (GLP-1 RA) is group of antidiabetic agents very effective in lowering the plasma glucose concentration in T2DM patients . Currently there are several agents approved for

sglt2 inhibitor
liraglutide
glucagon-like peptide 1 receptor agonist
semaglutide
glucagon-like peptide 1
  • 0 views
  • 25 Jan, 2021
  • 1 location
PIoglitazone for PrEvention of Restenosis in Diabetic Patients

stenting. Thiazolidinediones (TZDs), like pioglitazone (pio) or rosiglitazone, are a novel class of oral antidiabetic agents currently used to treat patients with type 2 diabetes mellitus

thiazolidinediones
diabetes
in stent restenosis
diet controlled
coronary angioplasty
  • 27 views
  • 07 Nov, 2020
  • 1 location
Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment

Investigators aim is to conduct an RCT to study the effect of adjunct metformin treatment to insulin monotherapy in patients with type 1 diabetes, targeting the intestinal incretin secretion. The patients will be randomly allocated to metformin or placebo treatment for 4 months

diabetes
incretin
metformin
insulin
type 1 diabetes mellitus
  • 2 views
  • 23 Jan, 2021
  • 1 location
Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production

Background The drug Jardiance treats diabetes. It lowers blood sugar by increasing glucose the kidneys excrete. This increases levels of ketones formed in the blood. The body makes ketones when it does not have enough glucose for fuel. The brains of many people with age-related diseases like Alzheimer s do …

  • 84 views
  • 26 Jan, 2021
  • 1 location
Dapagliflozin Plus Pioglitazone in T1DM

Purpose: To examine the effect of addition of combination therapy with dapagliflozin plus pioglitazone to insulin on glucose control and plasma ketone concentration in patients with type 1 diabetes (T1DM) Research Design: 120 patients with type 1 diabetes who otherwise are healthy constitute the study population. After screening, eligible subjects …

poor glycaemic control
diabetes
dapagliflozin
ketoacidosis
continuous glucose monitoring
  • 51 views
  • 14 Feb, 2021
  • 1 location
The Role of Glycocalyx Integrity in the Primary Prevention of Major Cardiovascular Events

We intend to recruit individuals who are referred for a routine screening in the primary prevention outpatient clinic of Attikon University hospital, Athens According to institutional protocols, a detailed medical history for atherosclerotic risk factors and current medication is recorded and a baseline clinical examination is performed. Moreover fasting blood …

  • 0 views
  • 28 Jan, 2021
  • 1 location